Physician profile
Robert D Blasberg
NPI 1922005487
$14,277.50
in general payments reported to CMS, 2019-2025
31 companies · $1,692 in 2025
The $1,692 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,978 · 2020: $1,644 · 2021: $2,205 · 2022: $2,166 · 2023: $1,988 · 2024: $1,605 · 2025: $1,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,431 · Travel and Lodging: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,431.02 |
| Travel and Lodging | $854.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,089.98 | 2019-2025 | Lensx, Clareon, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $2,824.00 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Catalys System |
| Carl Zeiss Meditec USA, INC. | $944.84 | 2022 | |
| Glaukos Corporation | $776.56 | 2019-2025 | |
| Abbvie INC. | $550.04 | 2022-2025 | Durysta |
| Carl Zeiss Meditec, INC. | $504.49 | 2019-2020 | |
| Coopervision INC. | $500.00 | 2021-2022 | |
| Eyepoint US, INC. | $377.79 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $311.63 | 2019-2021 | |
| New World Medical,INC. | $304.42 | 2022-2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Sight Sciences, INC. | $284.75 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Eyevance Pharmaceuticals LLC | $171.55 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $171.31 | 2019-2021 | |
| Shire North American Group INC | $142.67 | 2019 | |
| Allergan, INC. | $137.10 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $132.53 | 2022-2023 | Cequa |
| Alimera Sciences, INC. | $127.49 | 2019 | |
| Kala Pharmaceuticals, INC. | $126.03 | 2019 | |
| Biotissue Holdings INC. | $116.63 | 2024-2025 | |
| Rxsight INC | $105.57 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Astellas Pharma US INC | $104.63 | 2024 | Izervay |
| Bausch & Lomb Americas INC. | $104.52 | 2025 | Ic-8 Apthera Iol |
| Apellis Pharmaceuticals, INC. | $103.05 | 2024 | Syfovre |
| Novartis Pharmaceuticals Corporation | $86.14 | 2019-2021 | |
| Amgen INC. | $46.00 | 2024 | Tepezza |
| Horizon Therapeutics Plc | $33.71 | 2023 | Tepezza |
| Oyster Point Pharma, INC. | $23.59 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $21.75 | 2024 | Xdemvy |
| Ocular Therapeutix, INC. | $19.87 | 2019 | |
| Harrow Eye, LLC | $18.77 | 2024 | Vevye |
| Dompe US, INC. | $16.09 | 2024 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Blasberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.